ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Cambrex will up capacity at Iowa facility

by Rick Mullin
November 21, 2020 | APPEARED IN VOLUME 98, ISSUE 45

 

09845-buscon14-cambrex.jpg
Credit: Cambrex
Cambrex will expand this facility by 30%.

Citing growing demand for small-molecule drug development and production, Cambrex says it will spend $50 million to expand its capacity to make active pharmaceutical ingredients in Charles City, Iowa. The project will add three large-scale manufacturing centers and one midscale center, increasing the site’s capacity by 30% when completed in 2022. The expansion—the third in 8 years at the site—is expected to create 25 jobs, bringing employment there to 400.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment